Cogent Biosciences Inc

NASDAQ:COGT   10:08:13 AM EDT
7.96
-0.29 (-3.52%)
Earnings Announcements

Cogent Biosciences Provides Corporate Updates And Reports Q3 2021 Financial Results

Published: 11/10/2021 12:23 GMT
Cogent Biosciences Inc (COGT) - Cogent Biosciences Provides Corporate Updates and Reports Third Quarter 2021 Financial Results.
Cogent Biosciences Inc - Ended Q3 2021 With $202.9 Million in Cash, Sufficient to Fund Operations Into 2024.
Cogent Biosciences Inc - Net Loss Was $19.1 Million for Q3 Versus Net Loss of $50.0 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.46

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.39

More details on our Analysts Page.